mushroomreferences.com – Page 5 – A Curated List of References Relevant to Physicians, Scientists, and the Intellectually Curious

Psychedelic drugs are becoming accessible in the US through a patchwork of state legislative reforms. This shift necessitates consensus on treatment models, education and guidance…

Psychedelic Drug Legislative Reform and Legalization in the US

Psilocybin in Treatment-Resistant Depression

Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis

Pharmacokinetics and pharmacodynamics of oral psilocybin administration in healthy participants

Gut microbiota profiling in aged dogs after feeding pet food contained Hericium erinaceus

Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids

Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin

ANTIPROLIFERATIVE ACTIVITIES Of EXTRACTS FROM MYCELIAL BIOMASS OF SOME MEDICINAL BASIDIOMYCETES IN HUMAN COLON CANCER CELLS COLO 205

Hepatoprotective Activity of Ethanol Extract of Rice Solid-State Fermentation of Ganoderma tsugae against CCl4-Induced Acute Liver Injury in Mice

Body mass index (BMI) does not predict responses to psilocybin

Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice

Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice

Soil Disturbance Impact on Crop Ergothioneine Content Connects Soil and Human Health

The pharmacology of psilocybin

The crystal structure of baeocystin

Antioxidant studies of hispolon and its derivatives

Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial

Classic Psychedelics and Human-Animal Relations

Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls

Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity

Natural language signatures of psilocybin microdosing

Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression

Genes and evolutionary fates of the amanitin biosynthesis pathway in poisonous mushrooms

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

Enhanced Erinacine A Production by Hericium erinaceus Using Solid-State Cultivation

Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice

Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis